Form D · Biotechnology
Claris Biotherapeutics, Inc.
Half Moon Bay, CA · CIK 0001809726
Offering snapshot reported Aug 12, 2026 · SEC filing
- Reported sold
- $55.7M Offering amount: $121M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 25, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 12, 2026 | Amendment | $55,737,646 | $0vs Aug 7, 2026 | 14 | SEC filing |
| Aug 7, 2026 | Initial | $55,737,646 | No comparison | 14 | SEC filing |
| Mar 7, 2025 | Initial | $3,299,999 | No comparison | 6 | SEC filing |
| Jan 8, 2024 | Initial | $9,999,998 | No comparison | 3 | SEC filing |
| Oct 24, 2023 | Amendment | $44,499,994 | $5,999,998vs Jul 14, 2021 | 6 | SEC filing |
| Jul 14, 2021 | Amendment | $38,499,996 | No comparison | Not reported | SEC filing |
| Apr 27, 2020 | Initial | $11,846,938 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-593472
Source: Form D, filed Aug 12, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Clarke Atwell | Executive |
| Anton Clarke Atwell | Director, Executive |
| Brian Baum | Executive |
| Stephen Brady | Director, Executive |
| Reza Dana | Director |
| Marc De Garidel | Director |
| Michael Dybbs | Director |
| Meredith Fisher | Director |
| Kenneth Harrison | Director |
| Matt Hobson | Director |
| Susan Orr | Executive |
| Maha Radhakrishnan | Director |
| Henry Rath | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Half Moon Bay, CA, 94019
Phone: 201-344-7638